4.5 Editorial Material

Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of CTLA-4

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

Treating Cancer by Targeting the Immune System

Patrick Hwu

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Medicine, General & Internal

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Letter Medicine, General & Internal

Anti-CTLA4 Antibody-Induced Lupus Nephritis.

Fouad Fadel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Oncology

The role of the CTLA4 blockade in the treatment of malignant melanoma

Lee D. Cranmer et al.

CANCER INVESTIGATION (2007)

Article Medicine, General & Internal

Abatacept in the treatment of rheumatoid arthritis

D. J. Todd et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)

Article Multidisciplinary Sciences

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

GQ Phan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)